Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension
- PMID: 16339917
- PMCID: PMC2662954
- DOI: 10.1164/rccm.200509-1361OC
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension
Abstract
Rationale: Serotonin is a pulmonary vasoconstrictor and smooth muscle cell mitogen. The serotonin transporter (SERT) is abundant in pulmonary vascular smooth muscle. Compared with the short (S) allele, the long (L) SERT promoter allele is associated with increased SERT transcription and more severe pulmonary hypertension in a cohort of patients with chronic obstructive pulmonary disease, and was more prevalent in a cohort with idiopathic pulmonary arterial hypertension (IPAH), compared with control subjects.
Objective: We hypothesized that the SERT L allele would associate with an earlier age at diagnosis and/or shorter survival interval in pulmonary arterial hypertension (PAH) than the S allele.
Methods: SERT promoters from 166 familial PAH (FPAH), 83 IPAH, and 125 control subjects were sequenced. One hundred twenty-seven of the patients with FPAH had a known mutation in bone morphogenetic protein receptor 2 (BMPR2).
Results: The mean age at diagnosis was 35.8 yr in patients with FPAH and 41.1 yr in patients with IPAH (p = 0.02). There were no significant differences in distribution of the LL, LS, or SS genotypes in IPAH, FPAH, or unaffected BMPR2 mutation carriers. In FPAH, the LL genotype was associated with an earlier age at diagnosis (p < 0.02).
Conclusions: In patients with IPAH, these SERT genotypes do not correlate with age at diagnosis or survival interval. In patients with FPAH, the LL genotype correlates with an earlier age at diagnosis than SL or SS, although survival among the groups was similar. The correlation of the SERT promoter polymorphism with age at diagnosis in FPAH suggests a possible relationship between the SERT and BMPR2.
Figures




Similar articles
-
Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature.Metabolism. 2013 Dec;62(12):1867-75. doi: 10.1016/j.metabol.2013.08.012. Epub 2013 Sep 24. Metabolism. 2013. PMID: 24075737 Review.
-
[Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].Zhonghua Yi Xue Za Zhi. 2009 Feb 3;89(4):230-4. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19552837 Chinese.
-
Polymorphisms in the serotonin transporter protein (SERT) gene in patients with pulmonary arterial hypertension.Arch Bronconeumol. 2012 Mar;48(3):77-80. doi: 10.1016/j.arbres.2011.10.008. Epub 2011 Dec 16. Arch Bronconeumol. 2012. PMID: 22177971 English, Spanish.
-
Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.Respiration. 2010;79(4):279-87. doi: 10.1159/000250322. Epub 2009 Oct 17. Respiration. 2010. PMID: 19844076
-
5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis.Gene. 2019 Jan 5;680:34-42. doi: 10.1016/j.gene.2018.09.020. Epub 2018 Sep 12. Gene. 2019. PMID: 30218748 Review.
Cited by
-
The genomic complexity underlying pulmonary arterial hypertension: from mendel to networks.Am J Respir Crit Care Med. 2014 May 15;189(10):1152-4. doi: 10.1164/rccm.201403-0556ED. Am J Respir Crit Care Med. 2014. PMID: 24832737 Free PMC article. No abstract available.
-
Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.Am J Respir Crit Care Med. 2017 Jan 1;195(1):23-31. doi: 10.1164/rccm.201605-0905PP. Am J Respir Crit Care Med. 2017. PMID: 27398627 Free PMC article. No abstract available.
-
Proteomics of transformed lymphocytes from a family with familial pulmonary arterial hypertension.Am J Respir Crit Care Med. 2008 Jan 1;177(1):99-107. doi: 10.1164/rccm.200703-499OC. Epub 2007 Oct 11. Am J Respir Crit Care Med. 2008. PMID: 17932379 Free PMC article.
-
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.Am J Respir Crit Care Med. 2009 May 1;179(9):835-42. doi: 10.1164/rccm.200809-1472OC. Epub 2009 Feb 12. Am J Respir Crit Care Med. 2009. PMID: 19218192 Free PMC article.
-
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca2+ signaling.Physiol Rev. 2023 Jul 1;103(3):1827-1897. doi: 10.1152/physrev.00030.2021. Epub 2022 Nov 24. Physiol Rev. 2023. PMID: 36422993 Free PMC article. Review.
References
-
- Newman JH, Trembath RC, Morse JA, Grunig E, Loyd JE, Adnot S, Coccolo F, Ventura C, Phillips JA III, Knowles JA, et al. Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 2004;43(12, Suppl S):33S–39S. - PubMed
-
- Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, et al. Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop. Circulation 2004;109:2947–2952. - PubMed
-
- Cogan JD, Vnencak-Jones CL, Phillips JA III, Lane KB, Wheeler LA, Robbins IM, Garrison G, Hedges LK, Loyd JE, et al. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med 2005;7:169–174. - PubMed
-
- Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 1984;129:194–197. - PubMed
-
- Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000;37:741–745. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous